Skip to main content
. 2021 Jun 26;40:215. doi: 10.1186/s13046-021-02016-3

Fig. 1.

Fig. 1

The timeline of the current study and comprehensive genomic classification. A The timeline of ctDNA profiling and objective response evaluation. ctDNA profiling was performed at baseline and after 4 weeks. Objective response was evaluated by mRECIST after 6 weeks of treatment and every two months subsequently. B Comprehensive genomic classification related to HCC included in the Guardant360 panel